Castro, Julia T.; Azevedo, Patrick; Fumagalli, Marcílio Jorge; Hojo-Souza, Natalia S.; Salazar, Natalia; Almeida, Gregório G.; Oliveira, Livia I.; Faustino, Lídia; Antonelli, Lis R.; Marçal, Tomas G.; Augusto, Marconi; Valiate, Bruno; Fiorini, Alex; Rattis, Bruna Amanda da Cruz; Ramos, Simone Gusmão; Piccin, Mariela Pires Cabral; Nonato, Osvaldo Campos dos Santos; Benevides, Luciana; Magalhães, Rubens; Cassaro, Bruno; Burle, Gabriela; Doro, Daniel; Kalil, Jorge; Durigon, Edison Luiz 
; Salazar, Andrés; Caballero, Otávia; Santiago, Helton; Machado, Alexandre; Silva, João Santana da ; Fonseca, Flávio da; Fernandes, Ana Paula; Teixeira, Santuza R.; Gazzinelli, Ricardo Tostes
Fonte: Nature Communications. Unidades: FMRP, ICB
Assuntos: ANTICORPOS, LINFÓCITOS T, VACINAS, COVID-19, GLICOPROTEÍNAS, CORONAVIRUS
ABNT
CASTRO, Julia T. et al. Promotion of neutralizing antibody-independent immunity to wild-type and SARS-CoV-2 variants of concern using an RBD-Nucleocapsid fusion protein. Nature Communications, v. 13, n. 1, p. 1-16, 2022Tradução . . Disponível em: https://doi.org/10.1038/s41467-022-32547-y. Acesso em: 04 nov. 2024.APA
Castro, J. T., Azevedo, P., Fumagalli, M. J., Hojo-Souza, N. S., Salazar, N., Almeida, G. G., et al. (2022). Promotion of neutralizing antibody-independent immunity to wild-type and SARS-CoV-2 variants of concern using an RBD-Nucleocapsid fusion protein. Nature Communications, 13( 1), 1-16. doi:10.1038/s41467-022-32547-yNLM
Castro JT, Azevedo P, Fumagalli MJ, Hojo-Souza NS, Salazar N, Almeida GG, Oliveira LI, Faustino L, Antonelli LR, Marçal TG, Augusto M, Valiate B, Fiorini A, Rattis BA da C, Ramos SG, Piccin MPC, Nonato OC dos S, Benevides L, Magalhães R, Cassaro B, Burle G, Doro D, Kalil J, Durigon EL, Salazar A, Caballero O, Santiago H, Machado A, Silva JS da, Fonseca F da, Fernandes AP, Teixeira SR, Gazzinelli RT. Promotion of neutralizing antibody-independent immunity to wild-type and SARS-CoV-2 variants of concern using an RBD-Nucleocapsid fusion protein [Internet]. Nature Communications. 2022 ; 13( 1): 1-16.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1038/s41467-022-32547-yVancouver
Castro JT, Azevedo P, Fumagalli MJ, Hojo-Souza NS, Salazar N, Almeida GG, Oliveira LI, Faustino L, Antonelli LR, Marçal TG, Augusto M, Valiate B, Fiorini A, Rattis BA da C, Ramos SG, Piccin MPC, Nonato OC dos S, Benevides L, Magalhães R, Cassaro B, Burle G, Doro D, Kalil J, Durigon EL, Salazar A, Caballero O, Santiago H, Machado A, Silva JS da, Fonseca F da, Fernandes AP, Teixeira SR, Gazzinelli RT. Promotion of neutralizing antibody-independent immunity to wild-type and SARS-CoV-2 variants of concern using an RBD-Nucleocapsid fusion protein [Internet]. Nature Communications. 2022 ; 13( 1): 1-16.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1038/s41467-022-32547-y
